As Indonesia’s longest-established law firm (founded 1967), ABNR pioneered the development of international commercial law in the country following its reopening to foreign investment after a period of isolationism in the early 1960s.
Today, we believe our legal expertise and experience is second to none, as vouchsafed by our position as the exclusive Indonesia member firm for Lex Mundi (the leading global network of independent law firms).
We offer particular expertise in the Pharmaceuticals & Life Sciences sector, and count among our clients many of the largest multinational companies in the pharma, biotech, medical devices, diagnostics, veterinary and healthcare industries, whom we advise on such aspects as M&A, FDI, licensing & regulatory, capital markets and finance, product liability, halal compliance, and dispute resolution.
With over 100 lawyers, ABNR is the largest independent, full-service law firm in Indonesia and one of the country’s top-three law firms by number of fee earners, which gives us the scale needed to simultaneously handle even the largest and most complex transnational deals across a range of practice areas.
We continue to value the personal touch and are proud of our reputation for responsiveness. Our lawyers are business savvy and fully understand that — alongside legal expertise and experience — timeliness and value for money are of the utmost importance to our clients.
Ali Budiardjo, Nugroho, Reksodiputro
Graha CIMB Niaga 24th Floor
Jl. Jenderal Sudirman Kav.58
Jakarta 12190 Indonesia
Ph. +62 21 250 5125/5136
Fx. +62 21 250 5001/5121
The key facts about biosimilars and biologics in Indonesia. Prepared in association with ABNR, a leading global law firm, this is an extract from The Pharma Legal Handbook: Indonesia, available to purchase here for GBP 99. 1. Are biosimilar medicines considered the same as generic medicines in your country? No. Head of BPOM Regulation No. 17 of 2015 on Guidelines for Assessment of Biosimilar Products (“BPOM Reg 17/2015”) defines Biosimilar Product or Similar Biotherapeutic Product as a biological product with similar…
The low-down on the situation regarding cannabinoid drugs, medical cannabis and opioids in Indonesia. Prepared in association with ABNR, a leading global law firm, this is an extract from The Pharma Legal Handbook: Indonesia, available to purchase here for GBP 99. Cannabinoid Drugs 1. Are Cannabinoid Drugs authorized in your country? There is no definition of “Cannabinoid” under the Indonesian law. In general, under Law No. 35 of 2009 on Narcotics, as amended by Omnibus Law (“Narcotics Law”), all substances which…
Patents and trademarks in Indonesia – a comprehensive legal overview. Prepared in association with ABNR, a leading global law firm, this is an extract from The Pharma Legal Handbook: Indonesia, available to purchase here for GBP 99. 1. What are the basic requirements to obtain patent and trademark protection? In order to obtain patent or trademark protection, the applicant must register them with the Directorate General of Intellectual Property (“DGIP”). Trademark registrations are valid for 10 years and may be extended…